Global Ganja Report

An Australian woman who has long provided free cannabis oil products to the ailing had her home in the Adelaide suburb of Hiller raided by police Jan. 4. The South Australia Police "reported" Jenny Hallam, 44, for drug charges after the raid turned up cannabis products and equipment. Her lawyer, Heather Stokes, said Hallam gives away the products, and her actions should not be regarded as criminal.

Denver-based AmeriCann is planning to develop what will be the United States' largest medical marijuana facility in Freetown, Mass. At one million square feet, the Massachusetts Medical Cannabis Center is planned for a tract in the Bristol County town formerly slated for a brewery by the Boston Beer Co. Boston Business Journal reports that AmeriCann bought the property this fall for $4.475 million. AmeriCann CEO Tim Keogh said the facility will be "the place in the northeast US for the creation of a wide variety of exciting new advanced products for medical cannabis patients."

A little New York-California cross-fertilization of herbal consciousness took place as Martin Lee, the author of Smoke Signals: A Social History of Marijuana, spoke in Manhattan's East Village the night of Nov. 10 on "The Future of CBD and Medicinal Cannabis." Lee discussed his current work with California-based Project CBD, dedicated to promoting and publicizing research into the medical uses of cannabidiol, and Emerald Pharms, his CBD-oriented dispensary in Hopland, southern Medocino County. The event was hosted by The Alchemist's Kitchen, a New Age-flavored herbal apothecary—or "botanical dispensary"—on East 1st Street. Under New York state's medical marijuana law, the Kitchen recently launched a Bowery Cannabis Club, which specializes in CBD products.

The results of the Nov. 8 elections really indicate the schizophrenic nature of American political culture at this moment. Amid the fear and loathing over the election of the fascistic Donald Trump as president, big gains were registered for cannabis freedom. Voters in California approved Proposition 64, legalizing  up to an ounce for those 21 and older, and allowing individuals to grow up to six plants. The measure also permits retail sales and imposes a 15% tax. Similar measures passed in Massachusetts, Maine and Nevada, bringing the percentage of Americans living in states where cannabis is legal for adults up from five to 20 percent. Only Arizona's Proposition 205 was rejected by the voters.

Colombia has launched an ambitious initiative to provide a legal market for peasant cannabis cultivators, supplying a new facility that will produce extracts for the Israeli medical market. This week, the company One Colombia, which now produces coffee infused with medicinal herbs, broke ground on the plant at the highland town of Corinto, in the southern region of Cauca, Vanguardia newspaper reports. With an investment of $1.5 million from Israeli partners, the plant is projected to produce 300 tons of oil extracts annually, from 10 times as much "primary material"—all provided by local small producers.

Many rural California communities have high expectations over the prospect of commercial cannabis cultivation, officially licensed by local authorities under provisions of the Medical Cannabis Regulation and Safety Act (MMRCA), which was passed by Sacramento last year. Humbold County issued its first commercial cultivation licenses this summer. Now a less likely entry, Kern County in the conservative southern end of the Central Valley, has seen its first licenses. These were issued by the municipality of California City, where officials expressed some surprise at their own actions. "It's a new industry for us. It kind of came and dropped in our laps," city manager Tom Weil told Bakersfield's KBAK. "It's not something we were looking for."

The British government's Medicines & Healthcare Regulatory Agency (MHRA) on Oct. 11 issued a finding that cannabidiol (CBD) has a "restoring, correcting or modifying" effect on "physiological functions." The Independent calls the move "a potential milestone in the campaign to legalise cannabis and bring about evidence-based laws regarding drugs."  The review of CBD, a non-psychoactive cannabinoid increasingly studied for its therapeutic value, was undertaken following discussions with MediPen, a London-based company that seeks to market a CBD vaporizer.

German authorities just took the unprecedented move to allow a medical marijuana patient to cultivate at home. The obscurely named Federal Institute for Drugs and Medical Devices (BfArM) announced on Oct. 2 that a multiple sclerosis sufferer from Mannheim, in Baden-Württemberg state, will be permitted to grow a maximum of 130 plants a year. But the grow must be confined to an extremely restricted space in his bathroom. Terms of the permit stipulate that any leftover plants or harvested herb must be destroyed, and the buds must be kept in a "secure storage unit."